Moleculin Biotech, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $5.1M | $84.1M | $70.9M |
| FY2022 | $5.2M | $57.4M | $43.1M |
| FY2023 | $12.1M | $38.2M | $23.6M |
| FY2024 | $5.7M | $16.9M | $4.3M |
| FY2025 | $7.1M | $22.1M | $8.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $5.1M | $84.1M | $70.9M |
| FY2022 | $5.2M | $57.4M | $43.1M |
| FY2023 | $12.1M | $38.2M | $23.6M |
| FY2024 | $5.7M | $16.9M | $4.3M |
| FY2025 | $7.1M | $22.1M | $8.9M |